Precision BioSciences, Inc

DTILNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

26.4M

on 2026-06-30, from 6.92M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$250.0M

S-3 of 2025-12-30. None sold under it to 2026-10-05. S-3 ↗

$20.5M

Jefferies, agreement of 2025-03-26. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

8.61M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

6.7 quarters

$87.5M on 2026-06-30 ÷ $13.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-11-10	Public offering incl. 1.40M pre-funded, with warrants at $7.25	12,215,000	$6.14	$75.0M	424B5 ↗